Latest news
Expensify: Still Positive After Q2 Earnings Turnaround And Raised Cash Flow Guidance - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 13:45:00 GMTGEO's Q2 earnings beat estimates, guidance above consensus, operational updates positive (GEO:NYSE) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 12:09:54 GMTLSF Q1 2026 Earnings: Stunning EPS Beat Turns Profitability Positive - Guidance Update - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 00:31:17 GMTNICE Recommends Cytokinetics' MYQORZO for Obstructive Heart Muscle Disease - Stock TitanStock Titan · Thu, 30 Jul 2026 10:20:00 GMTCytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTALRS: Strong Q2 with EPS $0.81, improved credit, and positive outlook for growth and capital returns - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTFootball World Cup a positive for Adidas- guidance and tariffs in focus - FashionNetwork USAFashionNetwork USA · Mon, 27 Jul 2026 07:00:00 GMTSeatrium shares close 8.9% higher after positive profit guidance - The Business TimesThe Business Times · Mon, 27 Jul 2026 07:00:00 GMT